"USD Analytics | Business Consulting"North America is estimated to increase at a CAGR of 23.5 percent. Countries in the area, such as the United States and Canada, are taking steps to enhance the diagnosis and
The expected launch of therapies by several pharma companies such as ProKidney, Reata Pharmaceuticals, Inc., Novo Nordisk A/S, Boehringer Ingelheim, Eli Lilly and Company, AstraZeneca, and others
/PRNewswire/ DelveInsight s Chronic Kidney Disease Market Insights report includes a comprehensive understanding of current treatment practices, chronic.